The fusion of CASF with liposomes improved the transfection efficiency of the Lip/pDNA binary complex, reduced the expression of PLK1 protein, and improved the inhibitory ability of the Lip/pDNA complex on tumor cells. This evidence concerns the gene PLK1 and neoplasm.